XNAS · IMTX
+1.34% · +$0.1000 · Vol Not reported
Pre-market · updated 05:53:12 ET
Immatics N.V. Ordinary Shares

Immatics N.V. Ordinary Shares

$7.55
Card
Relationship Map

Follow $IMTX

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $IMTX by email

Veridion Score

BETAMEDIUM CONF · 6 of 6 factors measuredMethodology
IMTX
Immatics N.V. Ordinary Shares
Wed Oct 7 · last completed session · Pre-market · regular session opens 9:30 ET
Middle range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

49/ 100
Veridion Score
Middle range · MEDIUM confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 6 of 6 factors measured · Wed Oct 7 · last completed session · Pre-market · regular session opens 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is IMTX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading IMTX catalysts
About Immatics N.V. Ordinary Shares
Listed since
2020
Employees
407
Country
US

Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$7.45
Last session
Day high
$7.45
Last session
Day low
$7.45
Last session
Previous close
$7.45
52W high
$11.87
-36.39% from high
52W low
$7.45
2% of range
Market cap
$1.1B
Beta
0.82
Shares out
152.2M
Avg volume
766.4K
VWAP
$7.45
Last session
Price history computed in-house
1W
-10.55%
1M
-20.02%
3M
-22.00%
1Y
-27.19%
YTD
-28.10%
SMA 50 $8.96 · below
SMA 200 $9.82 · below
52W position 2%

IMTX overview

Veridion Score
49
Registered · 2026-10-07
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around IMTX.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading IMTX Form 4 filings
Public disclosures

Congress activity in IMTX

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified filings found.

Federal contracts

IMTX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for IMTX in this window.
Lobbying spend

IMTX lobbying filings, year to date.

Registered lobbying filings matched to Immatics N.V. Ordinary Shares.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for IMTX in this window.
Loading news for IMTX
Analyst ratings
Sovereign unlock shows live analyst consensus for IMTX.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.